Suraksha Diagnostic Ltd IPO
- Status: Upcoming
-
-
/
-
shares
Minimum Investment
IPO Listing Details
- Listing Date
06 Dec 2024
- Listing Price
₹437.00
- Listing Change
-0.91%
- Last Traded Price
₹412.15
IPO Details
- Open Date
TBA
- Close Date
TBA
- IPO
Price Range
TBA
- IPO
Size
TBA
- Listing Exchange
TBA
- Listing Date
TBA
IPO Timeline
Initial public offering of up to 19,189,330 equity shares of face value of Rs. 2 each of Suraksha Diagnostic Limited (the Company or the Issuer) for cash at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) (the Offer Price) aggregating up to Rs. [*] crores through an offer for sale of up to 19,189,330 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores, comprising up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Somnath Chatterjee, up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Ritu Mittal, up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Satish Kumar Verma (whose shares are jointly held with Suman Verma) (together with Somnath Chatterjee and Ritu Mittal, the Promoter Selling Shareholders), up to 10,660,737 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Orbimed Asia ii Mauritius Limited^ (the Investor Selling Shareholder), up to 799,556 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Munna Lal Kejriwal, and up to 1,332,593 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Santosh Kumar Kejriwal (together the Individual Selling Shareholders) (the promoter selling shareholders, the investor selling shareholder and the individual selling shareholders, collectively referred to as the Selling Shareholders, and such equity shares offered by the selling shareholders, the Offered Shares) (the Offer or the Offer for Sale). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company. ^ Surviving entity pursuant to amalgamation of orbimed asia ii mauritius fdi investments limited, the erstwhile shareholder, into orbimed asia ii mauritius limited. The face value of the equity shares is Rs. 2 each and the offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot will be determined by the company.
in 3easy steps
Using 5paisa App or
Website
to block Payment